Community Oncology Alliance and Community Oncology Pharmacy Association appoints advisory board

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

THE COMMUNITY ONCOLOGY ALLIANCE and the Community Oncology Pharmacy Association appointed its advisory board. Josh Cox and Tommy Harwood will serve as advisory board co-chairs. Board members include: Steve D’Amato, executive director, New England Cancer Specialists John Clagg, director of pharmacy and admixture services, The Center for Cancer and Blood Disorders Josh Cox, director of...

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

I have spent over 20 years running a tumor imaging metrics core at an academic cancer center. In that time, I have watched clinical trial enrollment concentrate at a relatively small number of flagship academic institutions. Unfortunately, trials do not propagate well to the community sites where most patients prefer to receive care. The explanations usually offered for why this happens have never fully accounted for what I observed.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login